We next examined the effect of NF‐κB on E2F6 expression by treatment and transfection of GBM cells with NF‐κB inhibitor JSH‐23 (10 × 10−6m) and RelA/p65 expression plasmid. The gene discussed is E2F6; the disease is glioblastoma.